Edwards Lifesciences (XSWX:EW) Non Operating Income: CHF-437 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:EW Edwards Lifesciences Corp XSWX:EW
98 GF Score
Price CHF71.64
GF Value CHF75.68
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Non Operating Income?

Edwards Lifesciences XSWX:EW 98 Non Operating Income is CHF-437 Mil as of Jun. 2026. GuruFocus rates XSWX:EW with a GF Score™ of 98/100 and a GF Value™ of CHF75.68. The stock has 5 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Edwards Lifesciences's Non Operating Income for the three months ended in Jun. 2026 was CHF-24 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-437 Mil.

Edwards Lifesciences Non Operating Income Related Terms

Edwards Lifesciences Non Operating Income Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Non Operating Income Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.02 -33.44 -141.31 -28.98 -407.77

Edwards Lifesciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.38 -91.79 -251.66 -70.23 -23.74
XSWX:EW
98GF Score
Edwards Lifesciences Corp XSWX:EW
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-437 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of CHF-437 Mil mean?
Edwards Lifesciences (XSWX:EW) has a Non Operating Income of CHF-437 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Non Operating Income too high?
Edwards Lifesciences' current Non Operating Income is CHF-437 Mil. Overall, Edwards Lifesciences has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Non Operating Income compare to BSX and DXCM?
Edwards Lifesciences' Non Operating Income of CHF-437 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Medical Devices & Instruments company?
A good Non Operating Income depends on the Medical Devices & Instruments industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Non Operating Income is CHF-437 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Edwards Lifesciences (XSWX:EW) has a current Non Operating Income of CHF-437 Mil. The stock's GF Value™ is CHF75.68, compared to a current price of CHF71.64 — trading 5.3% below its estimated fair value. The current Non Operating Income is CHF-437 Mil. Edwards Lifesciences' overall GF Score™ is 98/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Edwards Lifesciences (XSWX:EW), the current Non Operating Income is CHF-437 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of CHF71.64 is trading 5.3% below its estimated GF Value™ of CHF75.68.

Key valuation signals for XSWX:EW:

  • Non Operating Income: CHF-437 Mil
  • GF Value™: CHF75.68 vs. price of CHF71.64 (5.3% below fair value)
  • GF Score™: 98/100 with 5 warning signs

No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
98GF Score

Get the complete analysis for XSWX:EW

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.64
Price
CHF75.68
GF Value